Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Androgens like testosterone make Staphylococcus aureus skin infections more common in men.

2-Methoxyestradiol causes cancer cell death by activating specific pathways, but androgens can block this effect.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

DHT, a testosterone byproduct, causes male pattern baldness.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Testosterone protects female heart cells from stress by activating estrogen receptors.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Androgenetic alopecia is common hair loss due to genetics and DHT.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Women with keloid scars often have acne and hair loss, especially those with "true" keloids, indicating a possible hormonal imbalance.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

APKH in young males may signal early hair loss and needs early attention.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Androgens slow hair growth by altering Wnt signaling in balding cells.